| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| C9JR15 | SUN domain-containing protein 1; Fragment; | SUN1; | NULL | 88 | human |
| S4S3R8 | EZH2b; Enhancer of zeste homolog 2 (Drosophila); | EZH2; | NP_694543.1; | 707 | human |
| Q6VIM0 | Cytochrome c oxidase subunit 3; | COX3; CO3 COIII; | NULL | 261 | human |
| Q32MY8 | RUNX2 protein; | RUNX2; | NP_001265407.1; | 172 | human |
| Q5SU16 | Beta 5-tubulin; Beta-tubulin protein; Tubulin, beta; Tubulin, beta, isoform CRA_a; | TUBB; OK/SW-cl.56; | NP_821133.1; | 444 | human |
| B4DFT4 | ATP synthase subunit s-like protein; cDNA FLJ59869; | ATP5SL; | NULL | 178 | human |
| B4DTU4 | DNA ligase; EC 6.5.1.1; | LIG1; | NP_001275992.1; | 888 | human |
| M1LAK4 | Olfactomedin-like 3, isoform CRA_b; Olfactomedin-like protein 3; | OLFML3; | NP_064575.1; | 406 | human |
| A0A087WUS5 | Myc proto-oncogene protein; | MYC; | NULL | 454 | human |
| K7EM71 | Follistatin-related protein 3; | FSTL3; | NULL | 40 | human |
| Q5XRU6 | Cytochrome b; | CYTB; | NULL | 380 | human |
| F1T0D7 | LIM/homeobox protein Lhx3; | LHX3; | XP_005263467.1; | 386 | human |
| I3L0F9 | Putative protein TPRXL; | TPRXL; | NULL | 139 | human |
| A0A087WY13 | ADP-ribosylation factor-related protein 1; | ARFRP1; | NULL | 121 | human |
| A0A024QZE7 | Transforming growth factor beta 1 induced transcript 1, isoform CRA_a; | TGFB1I1; | NULL | 444 | human |
| B2RGG0 | Zinc finger and BTB domain containing 7C; Zinc finger and BTB domain-containing protein 7C; Fragment; | ZBTB7C; | NULL | 67 | human |
| E0YMJ8 | HNF1 beta A splice variant 3; Hepatocyte nuclear factor 1-beta; | HNF1B; | NULL | 425 | human |
| Q53GI4 | TEA domain family member 4 isoform 1 variant; Transcriptional enhancer factor TEF-3; Fragment; | TEAD4; | NULL | 434 | human |
| Q9B2X3 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| B4DZ84 | MAGUK p55 subfamily member 2; cDNA FLJ52373, highly similar to MAGUK p55 subfamily member 2; | MPP2; | NP_001265300.1;NP_001265302.1;NP_001265304.1; | 541 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |